Disseminating your research findings to a range of stakeholders is an important part of the research impact process. The key is to think about ‘who’ might possibly benefit from knowing more about your research, and importantly, ‘how’ could they use your findings to support, inform and develop their practice.
A good example of this process is the recent keynote address delivered by Prof. John Oliver (FMC) to more than 60 delegates at a one-day event that launched the new Centre of Excellence, Enterprise Portfolio Management Office (UK Parliament). Prof. Oliver’s talk entitled ‘Harnessing the Power of Scenario Planning’ presented the findings of his scenario-planning project that ultimately developed a mission, vision and strategy for the House of Commons Library Service in UK Parliament. Additional keynotes were given by the Chief Operating Officer (House of Lords) and a range of internal and external experts on project delivery and digital transformation.
Prof. Oliver’s work is published in Oliver, J.J., Reid, M., and Gray, K. (2023). The Library of the Future: a scenario-based approach. Journal of Library Administration, Volume 63, Issue 1, Pages
27-41













Dr. Paul Whittington attends Technology and the SEND Reforms Roundtable in the House of Commons
Dr. Paul Whittington joins Bett 2026 DfE Assistive Technology Roundtable
BU Prof Jonathan Parker promoting social work in Malaysia
New interdisciplinary paper accepted for publication
Three NIHR Internships awarded at BU
Research highlighted at the UN in New York
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease